Unknown

Dataset Information

0

Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies.


ABSTRACT: Multiple sclerosis (MS) therapy has evolved rapidly with an increased availability of several immunomodulating therapies over the past two decades. Disease-modifying therapies have proven to be effective in treating relapse-remitting MS (RRMS). However, clinical trials involving some of the same agents for secondary-progressive and primary-progressive MS (SPMS and PPMS) have been largely negative. The pathogenesis of progressive MS remains unclear, but B-cells may play a significant role in chronic compartmentalized inflammation, likely contributing to disease progression. Biologics targeted at B-cells, such as rituximab, are effective in treating RRMS. Ocrelizumab is a humanized monoclonal antibody to CD20+ B-cells that has shown positive results in PPMS with a significant reduction in disease progression. This review aims to discuss in detail the involvement of B-cells in MS pathogenesis, current progress of currently available and investigational biologics, with focus on ocrelizumab, and future prospects for B-cell therapy in PPMS.

SUBMITTER: Feng JJ 

PROVIDER: S-EPMC6053100 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies.

Feng Jenny J JJ   Ontaneda Daniel D  

Degenerative neurological and neuromuscular disease 20170201


Multiple sclerosis (MS) therapy has evolved rapidly with an increased availability of several immunomodulating therapies over the past two decades. Disease-modifying therapies have proven to be effective in treating relapse-remitting MS (RRMS). However, clinical trials involving some of the same agents for secondary-progressive and primary-progressive MS (SPMS and PPMS) have been largely negative. The pathogenesis of progressive MS remains unclear, but B-cells may play a significant role in chro  ...[more]

Similar Datasets

| S-EPMC7313157 | biostudies-literature
| S-EPMC8548959 | biostudies-literature
| S-EPMC8299560 | biostudies-literature
| S-EPMC8862399 | biostudies-literature
| S-EPMC5722762 | biostudies-literature
| S-EPMC9222195 | biostudies-literature
| S-EPMC8247316 | biostudies-literature
| S-EPMC6077906 | biostudies-other
| S-EPMC10014013 | biostudies-literature
| PRJNA966951 | ENA